About the Authors

Deus Thindwa

Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

deus.thindwa@yale.edu (DT), daniel.weinberger@yale.edu (DMW)

Affiliation Department of Epidemiology of Microbial Diseases and the Public Health Modeling Unit, Yale University, New Haven, Connecticut, United States of America

Paloma M. Carcamo

Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing

Affiliation Department of Epidemiology of Microbial Diseases and the Public Health Modeling Unit, Yale University, New Haven, Connecticut, United States of America

Ron Dagan

Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing

Affiliation The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

Daniel M. Weinberger

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

deus.thindwa@yale.edu (DT), daniel.weinberger@yale.edu (DMW)

Affiliation Department of Epidemiology of Microbial Diseases and the Public Health Modeling Unit, Yale University, New Haven, Connecticut, United States of America

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests; DT has received consulting fees from Vaxcyte for work unrelated to this manuscript. DMW has been principal investigator on grants from Pfizer and Merck to Yale University for work unrelated to this manuscript and has received consulting and/or speaking fees from Pfizer, Merck, and GSK/Affinivax. The other authors declare no competing interests.